Uridine 5'‑diphospho‑glucronosyltrasferase: Its role in pharmacogenomics and human disease (Review)

Abstract. Biotransformation is an enzyme-catalyzed process in which the body converts endogenous compounds, xenobiotics and toxic substances into harmless or easily excreted metabolites. The biotransformation reactions are classified as phase I and II reactions. Uridine 5'-diphospho (UDP)-glucu...

Full description

Bibliographic Details
Main Authors: Sánchez Domínguez, Celia Nohemí, Gallardo Blanco, Hugo Leonid, Salinas Santander, Mauricio Andrés, Ortiz López, Rocío
Format: Article
Language:English
Published: 2018
Online Access:http://eprints.uanl.mx/16193/1/110.pdf
_version_ 1824414529996455936
author Sánchez Domínguez, Celia Nohemí
Gallardo Blanco, Hugo Leonid
Salinas Santander, Mauricio Andrés
Ortiz López, Rocío
author_facet Sánchez Domínguez, Celia Nohemí
Gallardo Blanco, Hugo Leonid
Salinas Santander, Mauricio Andrés
Ortiz López, Rocío
author_sort Sánchez Domínguez, Celia Nohemí
collection Repositorio Institucional
description Abstract. Biotransformation is an enzyme-catalyzed process in which the body converts endogenous compounds, xenobiotics and toxic substances into harmless or easily excreted metabolites. The biotransformation reactions are classified as phase I and II reactions. Uridine 5'-diphospho (UDP)-glucuronosyltransferases (UGTs) are a superfamily of phase II enzymes which have roles in the conjugation of xenobiotics or endogenous compounds, including drugs and bilirubin, with glucuronic acid to make them easier to excrete. The method the human body uses to achieve glucuronidation may be affected by a large interindividual variation due to changes in the sequences of the genes encoding these enzymes. In the last five years, the study of the genetic variants of the UGTs at a molecular level has become important due to its association with several diseases and the ability to predict adverse events due to drug metabolism. In the present review, the structure and the prominent genetic variants of the UGT1A subfamily and their metabolic and clinical implications are described.
format Article
id eprints-16193
institution UANL
language English
publishDate 2018
record_format eprints
spelling eprints-161932020-06-09T20:58:38Z http://eprints.uanl.mx/16193/ Uridine 5'‑diphospho‑glucronosyltrasferase: Its role in pharmacogenomics and human disease (Review) Sánchez Domínguez, Celia Nohemí Gallardo Blanco, Hugo Leonid Salinas Santander, Mauricio Andrés Ortiz López, Rocío Abstract. Biotransformation is an enzyme-catalyzed process in which the body converts endogenous compounds, xenobiotics and toxic substances into harmless or easily excreted metabolites. The biotransformation reactions are classified as phase I and II reactions. Uridine 5'-diphospho (UDP)-glucuronosyltransferases (UGTs) are a superfamily of phase II enzymes which have roles in the conjugation of xenobiotics or endogenous compounds, including drugs and bilirubin, with glucuronic acid to make them easier to excrete. The method the human body uses to achieve glucuronidation may be affected by a large interindividual variation due to changes in the sequences of the genes encoding these enzymes. In the last five years, the study of the genetic variants of the UGTs at a molecular level has become important due to its association with several diseases and the ability to predict adverse events due to drug metabolism. In the present review, the structure and the prominent genetic variants of the UGT1A subfamily and their metabolic and clinical implications are described. 2018-11-17 Article PeerReviewed text en cc_by_nc_nd http://eprints.uanl.mx/16193/1/110.pdf http://eprints.uanl.mx/16193/1.haspreviewThumbnailVersion/110.pdf Sánchez Domínguez, Celia Nohemí y Gallardo Blanco, Hugo Leonid y Salinas Santander, Mauricio Andrés y Ortiz López, Rocío (2018) Uridine 5'‑diphospho‑glucronosyltrasferase: Its role in pharmacogenomics and human disease (Review). Experimental and Therapeutic Medicine. pp. 3-11. ISSN 1792-0981 http://doi.org/10.3892/etm.2018.6184 doi:10.3892/etm.2018.6184
spellingShingle Sánchez Domínguez, Celia Nohemí
Gallardo Blanco, Hugo Leonid
Salinas Santander, Mauricio Andrés
Ortiz López, Rocío
Uridine 5'‑diphospho‑glucronosyltrasferase: Its role in pharmacogenomics and human disease (Review)
thumbnail https://rediab.uanl.mx/themes/sandal5/images/online.png
title Uridine 5'‑diphospho‑glucronosyltrasferase: Its role in pharmacogenomics and human disease (Review)
title_full Uridine 5'‑diphospho‑glucronosyltrasferase: Its role in pharmacogenomics and human disease (Review)
title_fullStr Uridine 5'‑diphospho‑glucronosyltrasferase: Its role in pharmacogenomics and human disease (Review)
title_full_unstemmed Uridine 5'‑diphospho‑glucronosyltrasferase: Its role in pharmacogenomics and human disease (Review)
title_short Uridine 5'‑diphospho‑glucronosyltrasferase: Its role in pharmacogenomics and human disease (Review)
title_sort uridine 5 diphospho glucronosyltrasferase its role in pharmacogenomics and human disease review
url http://eprints.uanl.mx/16193/1/110.pdf
work_keys_str_mv AT sanchezdominguezcelianohemi uridine5diphosphoglucronosyltrasferaseitsroleinpharmacogenomicsandhumandiseasereview
AT gallardoblancohugoleonid uridine5diphosphoglucronosyltrasferaseitsroleinpharmacogenomicsandhumandiseasereview
AT salinassantandermauricioandres uridine5diphosphoglucronosyltrasferaseitsroleinpharmacogenomicsandhumandiseasereview
AT ortizlopezrocio uridine5diphosphoglucronosyltrasferaseitsroleinpharmacogenomicsandhumandiseasereview